SCD and fatty liver disease: Mice with a targeted disruption of the Scd1 gene have very low levels of VLDL and impaired triglyceride and cholesterol ester biosynthesis, as well as markedly reduced adiposity and decreased hepatic steatosis on both lean and ob / ob background despite higher food intake [37, 38].